LANSING, Mich. — Neogen Corporation (NASDAQ: NEOG) announced today that Dr. Daniel Kephart, formerly chief scientific officer, has resigned from the company to pursue alternative opportunities. Dr. Kephart had served in this capacity since December 2016. Neogen Corporation develops and markets products dedicated to food and animal safety. The company’s Food Safety Division markets dehydrated […]
Early Evaluators Report Faster Sequencing and Consistent Quality at a Lower Cost SHENZHEN, China — MGI Tech, a subsidiary corporation of BGI, launched two new next generation genetic sequencers, MGISEQ-2000 and MGISEQ-200, at the 12th International Conference on Genomics (ICG-12) in Shenzhen. The products were unveiled at the conference, held at the China National GeneBank from Oct. […]
Avalon Forms Subsidiary U.S. Company, GenExosome Technologies Inc., for the Global Advancement of Exosome Technology for Diagnosis and Treatment of Diseases FREEHOLD, NJ — Avalon GloboCare Corp. (OTCQB: AVCO), a leading global developer of cell-based technologies, announced today that its majority-owned subsidiary GenExosome Technologies Inc. (GenExosome) acquired 100% of the outstanding capital stock of Beijing Jieteng (Beijing GenExosome) […]
Trusted QIAGEN partners can now increase their speed to market by leveraging the company’s industry expertise, world-class manufacturing and thousands of product formulations Beverly, Mass. – QIAGEN today announced the launch of its Custom Solutions business, extending its commitment to providing life sciences and molecular diagnostics companies with the tools and expertise required to quickly build […]
Call to unite stakeholders and experts Leuven – The world-leading research and innovation hub in nano-electronics and digital technologies imec announced today that is has joined ORCHID, a European initiative that will establish a European infrastructure to enable coordinated development, production and implementation of Organs-on-Chips by a consortium of academic and private partners. In total six […]
BioFront Technologies has announced that UK’s Biorex Food Diagnostics has appointed the company as its USA distributor for its food safety diagnostic platform. Biorex products include an extensive range of antibiotics, mycotoxins, hormones and beta-agonists. Biorex customers in the UK and around the globe will also have access to Biofront’s comprehensive Food Allergen test kit […]
Multiplex assays have been plagued by a lack of specificity and accuracy, with unreliable data as a result. However, a new multiplex assay has reached the US market. Mercodia, based in Sweden, has teamed-up with Quansys Biosciences, based in the US, to launch the AKURIO Islet Hormones multiplex assay, which measures four of the most […]
Collaboration will use PanCancer IO360 Assay Which Incorporates the Tumor Inflammation Signature (TIS) and mismatch repair genes (MMR) for assessment of MSI-H phenotype SEATTLE and PITTSBURGH — NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, and the NSABP Foundation, Inc. (NSABP), an academic research organization supported by the National Cancer Institute (NCI) and industry funding, […]
Charles River to license PDX lines to InSphero for development of 3D InSight™ PDX Microtissues, expansion of in vitro oncology services. PDF Version Schlieren, Switzerland InSphero AG and Charles River Laboratories International, Inc. today announced a partnership through which Charles River will license its collection of patient-derived xenograft (PDX) tumors to InSphero. Additionally, Charles River will leverage InSphero’s […]
Illumina and Pillar Biosciences, Inc. today announced an agreement to develop next-generation sequencing (NGS) based in vitro diagnostic (IVD) tests. Under the terms of the agreement, Pillar Biosciences will lead the development of a series of diagnostic tests that will be run on the Illumina MiSeq™Dx instrument. Pillar Biosciences has developed Stem Loop Inhibition Mediated […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
